Skip to main content
SpringerLink
Log in

Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Monosomal karyotype (MK) in acute myeloid leukemia (AML) is associated with an extremely poor outcome. The clinical significance of MK and the role of allogeneic hematopoietic cell transplantation (HCT) were evaluated in 749 Korean patients with newly diagnosed AML. MK was found in 9.3 % of patients and was more frequent in patients with advanced age or secondary AML. Patients with MK had significantly lower blood leukocyte counts and bone marrow blast percentages, and they had lower complete remission (CR) rate (43 %) and shorter median overall survival (OS) (6.5 months) and relapse-free survival (RFS) (10.0 months) than any other prognostic group. MK+ patients who received allogeneic HCT at the first CR had higher OS [hazard ratio (HR) 0.344, P = 0.018], RFS (HR 0.257, P = 0.006), and lower relapse probability (HR 0.264, P = 0.008) than those not receiving. This study’s results confirmed poor outcomes for AML patients with MK and suggest that allogeneic HCT at the first CR may improve outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Grimwade D, Hills RK, Moorman AV et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354–365. doi:10.1182/blood-2009-11-254441

    Article  CAS  PubMed  Google Scholar 

  2. Grimwade D, Hills RK (2009) Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program:385–395. doi:10.1182/asheducation-2009.1.385

  3. Mrozek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136. doi:10.1016/S0268-960X(03)00040-7

    Article  PubMed  Google Scholar 

  4. Slovak ML, Kopecky KJ, Cassileth PA et al (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 96:4075–4083

    CAS  PubMed  Google Scholar 

  5. Mrozek K, Bloomfield CD (2006) Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematology Am Soc Hematol Educ Program:169–177. doi:10.1182/asheducation-2006.1.169

  6. Breems DA, Van Putten WL, De Greef GE et al (2008) Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791–4797. doi:10.1200/JCO.2008.16.0259

    Article  PubMed  Google Scholar 

  7. Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR (2010) Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 116:2224–2228. doi:10.1182/blood-2010-02-270330

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Kayser S, Zucknick M, Dohner K et al (2012) Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 119:551–558. doi:10.1182/blood-2011-07-367508

    Article  CAS  PubMed  Google Scholar 

  9. Haferlach C, Alpermann T, Schnittger S et al (2012) Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype. Blood 119:2122–2125. doi:10.1182/blood-2011-10-385781

    Article  CAS  PubMed  Google Scholar 

  10. Voutiadou G, Papaioannou G, Gaitatzi M et al (2013) Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk category. Cancer Genet 206:32–36. doi:10.1016/j.cancergen.2012.10.003

    Article  PubMed  Google Scholar 

  11. Cornelissen JJ, van Putten WL, Verdonck LF et al (2007) Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood 109:3658–3666. doi:10.1182/blood-2006-06-025627

    Article  CAS  PubMed  Google Scholar 

  12. Koreth J, Schlenk R, Kopecky KJ et al (2009) Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301:2349–2361. doi:10.1001/jama.2009.813

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Cornelissen JJ, Breems D, van Putten WL et al (2012) Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. J Clin Oncol 30:2140–2146. doi:10.1200/JCO.2011.39.6499

    Article  PubMed  Google Scholar 

  14. Tomonaga M (2009) Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues. Rinsho Ketsueki 50:1401–1406. doi:JST.JSTAGE/rinketsu/50.1401 [pii]

  15. Fernandez-Mercado M, Yip BH, Pellagatti A et al. (2012) Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics. PLoS One 7:e42334. doi:10.1371/journal.pone.0042334 PONE-D-12-10403 [pii]

  16. Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21:4642–4649. doi:10.1200/JCO.2003.04.036

    Article  PubMed  Google Scholar 

  17. Ahn HK, Jang JH, Kim K et al (2012) Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity. Am J Hematol 87:37–41. doi:10.1002/ajh.22193

    Article  CAS  PubMed  Google Scholar 

  18. Perrot A, Luquet I, Pigneux A et al (2011) Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood 118:679–685. doi:10.1182/blood-2010-09-307264

    Article  CAS  PubMed  Google Scholar 

  19. Stelljes M, Beelen DW, Braess J et al (2011) Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial. Haematologica 96:972–979. doi:10.3324/haematol.2011.041004

    Article  PubMed Central  PubMed  Google Scholar 

  20. Fang M, Storer B, Estey E et al (2011) Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 118:1490–1494. doi:10.1182/blood-2011-02-339721

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Yanada M, Kurosawa S, Yamaguchi T et al. (2012) Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission. Haematologica 97:915–918. doi:haematol.2011.058289 [pii] 10.3324/haematol.2011.058289

  22. Oran B, Dolan M, Cao Q, Brunstein C, Warlick E, Weisdorf D (2011) Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 17:356–364. doi:S1083-8791(10)00224-7 [pii] 10.1016/j.bbmt.2010.05.012

Download references

Acknowledgments

Yunsuk Choi analyzed the data and wrote the manuscript; Je-Hwan Lee designed the study, analyzed the data, and contributed to the writing of the manuscript; Eul-Ju Seo, Chan-Jung Park, Seongsoo Jang, Young-Uk Cho analyzed data; Jung-Hee Lee, Dae-Young Kim, Miee Seol, Young-Shin Lee, Young-A Kang, Mijin Jeon and Kyoo-Hyung Lee collected the clinical data. All authors participated in the critical revision of the manuscript, and each gave final approval for the submission of this manuscript. This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. HI06C0868 (A062254)

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro-43-gil, Songpa-gu, Seoul, 138-736, Korea

    Yunsuk Choi, Je-Hwan Lee, Jung-Hee Lee, Dae-Young Kim, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon & Kyoo-Hyung Lee

  2. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    Eul-Ju Seo, Chan-Jung Park, Seongsoo Jang & Young-Uk Cho

Authors
  1. Yunsuk Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Je-Hwan Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eul-Ju Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jung-Hee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dae-Young Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chan-Jung Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seongsoo Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Young-Uk Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Miee Seol
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Young-Shin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Young-Ah Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mijin Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Kyoo-Hyung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Je-Hwan Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, Y., Lee, JH., Seo, EJ. et al. Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation. Ann Hematol 94, 795–801 (2015). https://doi.org/10.1007/s00277-014-2286-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2286-7

Keywords

Search

Navigation